CLINICAL TRIALS PROFILE FOR PARICALCITOL
✉ Email this page to a colleague
All Clinical Trials for Paricalcitol
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00048438 ↗ | Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) | Completed | Abbott | Phase 3 | 2002-02-01 | The objective of this study is to determine whether paricalcitol is safe and effective compared to placebo in reducing elevated serum PTH levels in patients with chronic kidney disease. |
NCT00048451 ↗ | Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) | Completed | Abbott | Phase 3 | 2002-02-01 | The objective of this study is to determine whether paricalcitol is safe and effective compared to placebo in reducing elevated serum PTH levels in patients with chronic kidney disease. |
NCT00048516 ↗ | Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing) | Completed | Abbott | Phase 3 | 2002-02-01 | The objective of this study is to determine whether paricalcitol is safe and effective compared to placebo in reducing elevated serum PTH levels in patients with chronic kidney disease. |
NCT00064376 ↗ | Paricalcitol in Treating Patients With Myelodysplastic Syndrome | Completed | Abbott | Phase 2 | 2003-05-01 | RATIONALE: Paricalcitol is a form of vitamin D that may help myelodysplastic cells develop into normal bone marrow cells. PURPOSE: Phase II trial to study the effectiveness of paricalcitol in treating patients who have myelodysplastic syndrome. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Paricalcitol
Condition Name
Clinical Trial Locations for Paricalcitol
Trials by Country
Clinical Trial Progress for Paricalcitol
Clinical Trial Phase
Clinical Trial Sponsors for Paricalcitol
Sponsor Name